We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Selective Use of D-Dimer Test for Deep Vein Thrombosis

By LabMedica International staff writers
Posted on 30 Jan 2013
Print article
D-dimer testing based on clinical pretest probability for deep vein thrombosis (DVT) is safe and reduces diagnostic testing compared with checking all patients.

D-dimer testing is sensitive but not specific for DVT and changing the threshold level for a positive test result based on risk for DVT might improve the tradeoff between sensitivity and specificity and reduce the need for testing.

Scientists from McMaster University, (Hamilton, ON, Canada) randomly assigned 1,723 outpatients presenting for the first time with symptoms of DVT to selective testing for D-dimer for patients with low or moderate clinical pretest probability of DVT. Some patients with high clinical pretest probability had venous ultrasonograpy without D-dimer testing and some patients presenting with symptoms had uniform testing. The study groups were all consecutive symptomatic patients with a first episode of suspected DVT from five different hospitals.

Selective testing of 860 patients, defined as d-dimer testing for outpatients with low or moderate clinical pretest probability (C-PTP), where DVT excluded at d-dimer levels of equal to or less than 1.0 µg/mL, a low C-PTP or equal to or less than 0.5 µg/mL, moderate C-PTP. The groups who had venous ultrasonography without d-dimer testing for outpatients with high C-PTP and inpatients, or the 863 uniform testing defined as d-dimer testing for all participants where DVT was excluded at d-dimer levels of less than 0.51 µg/mL.

The incidence of symptomatic venous thromboembolism at three months was 0.5% in both study groups. Selective testing reduced the proportion of patients who required d-dimer testing by 21.8% and reduced the proportion that required ultrasonography by 7.6 % overall and by 21.0% in outpatients with low C-PTP. The authors concluded that a selective d-dimer testing strategy seems as safe as and more efficient than having everyone undergo d-dimer testing when diagnosing a first episode of suspected DVT. The study was published on January 15, 2013, in the journal Annals of Internal Medicine.

Related Links:

McMaster University



Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Immunofluorescence Analyzer
MPQuanti
New
H.pylori Test
Humasis H.pylori Card

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.